Clinical Trial Update: Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis [Phase 2]

View source ↗

Summary

Phase II study of Gusperimus in patients with refractory granulomatosis with polyangiitis (Wegener's granulomatosis) has been completed; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis

Drugs mentioned

• Gusperimus (Gusperimus)

Snippet

Sponsor: Nippon Kayaku Co., Ltd. | Conditions: Wegener's Granulomatosis | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06